News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Galapagos NV Sees More Deals After Roche (JOBS) Agreement; Galapagos to Gets 6 Million Euros Upfront Payment
January 11, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Belgian biotech company Galapagos has signed a global development deal with Swiss drugmaker Roche (ROG.VX), and said it was in a research sweet spot that could see more deals signed this year.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Roche
MORE ON THIS TOPIC
Drug pricing
Pfizer Leads Industry-Wide Surge in Drug Prices for 2026 Despite Political Pressure
January 2, 2026
·
2 min read
·
Nick Paul Taylor
Legal
Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme
December 23, 2025
·
2 min read
·
Nick Paul Taylor
IPO
Radiopharma-Focused Aktis Squeezes in IPO To End Biotech Drought
December 22, 2025
·
1 min read
·
Annalee Armstrong
China
AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor
December 22, 2025
·
1 min read
·
Annalee Armstrong